Business Wire

QUECTEL-WIRELESS

29.11.2022 09:01:40 CET | Business Wire | Press release

Share
Quectel Drives Digital Transformation of Energy Market to Help Resolve Global Energy Crisis

Quectel Wireless Solutions, a global IoT solutions provider, today highlights its extensive range of IoT solutions that will drive digital transformation in today’s energy market, helping to counter the issues faced through today’s energy crisis.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221129005119/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Quectel drives digital transformation of energy market to help resolve global energy crisis (Photo: Business Wire)

Smart metering, smart grids and smart home applications are all starting to use advanced technologies for insights and efficiencies in their sector, including cloud computing, edge computing and data and analytics. Automation, robotics, IoT, artificial intelligence, digital twins, and many other technologies are all also becoming increasingly critical to help accelerate deployments in this sector.

Smart meters, intelligent grids and cloud-based platforms will allow customers to pay only for what they use, while in the automotive world, indicators suggest that advanced driver assistance systems will enable a saving of 400,000 metric tons of CO2 per year, through efficiency gains per mile driven. Quectel’s broad portfolio of modules and antennas, alongside the recently launched connectivity service, means it is uniquely positioned to support these initiatives and others like them with effective wireless connectivity, providing the IoT solutions needed to help drive this digital transformation.

“The current energy crisis means we are seeing a meaningful need to manage our energy requirements, both from a supply and cost point of view,” said Norbert Muhrer, President and CSO, Quectel Wireless Solutions. “Technologies that we’re seeing today, whether it’s smart metering, smart grids, automotive systems or smart charging posts are one such way that we can optimize our use of energy and alleviate some of these issues that we’re seeing across the world.”

The utilities sector is a natural fit for connected technologies and is already being fundamentally transformed through IoT development. In a sector where assets are frequently in remote or hard-to-reach locations, the value of reliable connectivity – with minimal demands on power and maintenance – is clear. Previously used for 2G, the LTE 450 band is increasingly used as a network for IoT and critical applications and is ideal for the wide area coverage that IoT demands. Quectel modules that support LTE 450 such as the EG921N-EN, an LTE Cat 1 wireless communication module is optimized especially for M2M and IoT applications and is ideal for home smart meters.

Other modules that are ideal to help drive the transformation of the utility industry include the industrial standard Wi-Fi & Bluetooth 5.2 FC41D module, designed to meet the requirements of low flow control and data acquisition applications such as smart homes and industrial control and the BC660K-GL, designed specifically to meet the needs of the smart metering industry.

Furthermore, Quectel’s extensive module portfolio and its comprehensive range of antennas can offer charging point operators the capabilities they need to facilitate connectivity for their charging points. The BG950 and BG951 LTE Cat M1 modules offer ultra-low power consumption, ideal for periods of non-use at charging points while the EG91 series and EG915 series offer potentially even better performance across LTE Cat 1 for electric vehicle charging points.

The Quectel module offering is complemented by its range of antennas which help optimize connection efficiency and aid ease of installation of devices. These can be supplied pre-integrated with Quectel IoT modules to accelerate time to market and help eliminate commonly found integration issues. At the same time, completing the module and antenna range, the Connectivity-as-a-Service offering adds connectivity to the portfolio available and helps customers to simplify the journey of designing, building, connecting, and commercializing their IoT offerings.

More information on Quectel modules and antennas can be found here on our website https://www.quectel.com/shop/ and here antennas

Download our white paper on Smart Meters here: https://www.quectel.com/library/why-cellular-connectivity-provides-the-robust-secure-foundation-for-new-revenues-in-smart-metering

Download our white paper on LTE 450 here: https://www.quectel.com/library/why-lte-450-is-the-enabler-of-critical-long-range-communications

Download our white paper on EV charging here: https://www.quectel.com/library/ev-charging-white-paper

About Quectel

Quectel’s passion for a smarter world drives us to accelerate IoT innovation. A highly customer-centric organization, we are a global IoT solutions provider backed by outstanding support and services. Our growing global team of over 4,000 professionals sets the pace for innovation in cellular, GNSS, Wi-Fi and Bluetooth modules, antennas and IoT connectivity.

With regional offices and support across the globe, our international leadership is devoted to advancing IoT and helping build a smarter world.

For more information: www.quectel.com, LinkedIn, Facebook, and Twitter.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221129005119/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vensica Medical Receives FDA IND Clearance to Initiate Phase 2 Study of ViXe, Its Needle-Free Xeomin® Delivery System for Overactive Bladder28.4.2026 14:42:00 CEST | Press release

Vensica Medical, a clinical-stage company developing needle-free therapeutic delivery solutions for urologic diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application to initiate a Phase 2 clinical trial of ViXe. The study will evaluate the Vibe® ultrasound-based, needle-free drug delivery system in combination with Xeomin® (incobotulinumtoxinA) for the treatment of overactive bladder (OAB). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414145279/en/ Avner Geva, Cofounder, CEO (left), and Avi Eftel, Cofounder, CTO (right) Overactive bladder affects an estimated 33 million adults in the United States and is characterized by urinary urgency, frequency, and incontinence. While intravesical botulinum toxin injection is an established second-line treatment, the invasive procedure limits patient access and acceptance. The ViXe program is desi

Printing the Future of Oncology: CTIBIOTECH Invests €3M and Secures €1.25M from France 2030 to Revolutionize Personalized Cancer Care28.4.2026 14:28:00 CEST | Press release

CTIBIOTECH™, a leading innovator in advanced human tissue engineering, proudly announces CTIONCOTEST™ platform is awarded Major Bpifrance Funding to Industrialize 3D Bioprinted Cancer Models CTIBIOTECH Announces the CTIONCOTEST ™ Project to Revolutionize Cancer Research with 3D Bioprinted Microtumors, Backed by France 2030 and Bpifrance This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260428242352/en/ The CTIONCOTEST™ platform by CTIBIOTECH is an innovative 3D bioprinting technology that revolutionizes preclinical cancer research . It provides an automated, industrial-scale process to produce high-throughput, patient-specific human "microtumors" directly from primary tumor cells . Designed to tackle the 95% clinical failure rate of new cancer drugs, it faithfully replicates the complex tumor microenvironment, including critical hypoxic and necrotic zones . Targeting high-mortality breast, colon, and pancreatic cancers, the pla

BMG and Concord Combine to Create World’s Leading Independent Music Company28.4.2026 14:11:00 CEST | Press release

Creates global platform to deliver superior service to artists, songwriters, and partnersUnlocks meaningful value through greater scale and strong cash flow, enabling continued investment in music rights, creative talent, and technologyBob Valentine to serve as CEO and Thomas Coesfeld as Chairman of the combined company, with global headquarters in Nashville and European Headquarters in BerlinCombined company to be named BMG with divisions “BMG Publishing” and “Concord Records” BMG and Concord today announced a definitive agreement to combine their businesses, creating the leading independent music company in the world. Operating under the BMG name, the combined company will bring together two highly complementary businesses to establish a scaled, global company delivering superior service to artists, songwriters, and partners – firmly grounded in an independent, artist-first model. This press release features multimedia. View the full release here: https://www.businesswire.com/news/ho

Masimo SET® Pulse Oximetry Performed Accurately on Hospitalized Newborns of All Skin Tones in Largest-Ever Prospective Real-World Study28.4.2026 14:00:00 CEST | Press release

NICU Study Adds to the Evidence Demonstrating SET®’s Accuracy in Challenging Real-World Settings, With No Clinically Significant Differences in Performance Across Skin Pigmentation Categories or Race and Zero Occult Hypoxemia in Black or Hispanic Newborns Masimo (NASDAQ: MASI) today announced the findings of a study evaluating the accuracy of Masimo SET® pulse oximetry among critically ill neonates and demonstrating less than 1% overall statistical bias. Importantly, there were no clinically meaningful skin pigmentation-related discrepancies and no occult hypoxemic events among Black or Hispanic patients, and in only one Caucasian patient overall. The Neonatal Pulse Oximetry Accuracy and Disparities by Skin Pigmentation (NeoPODS) study findings were presented from the podium at the Pediatric Academic Society in Boston, MA on Monday, April 27th at 10 am EST by lead author Dr. Heather Siefkes on behalf of colleagues at the University of California, Davis and the University of Mississippi

KAYTUS AI Compute Pod Wins 2026 iF Design Award and Red Dot Award, Setting a New Standard for AI Data Center28.4.2026 11:54:00 CEST | Press release

Delivering up to 130kW of liquid cooling per rack, the solution synchronizes cooling output with IT load in real time within seconds, to support high-density AI, large-scale computing, and HPC deployments, while reducing build time by 70% KAYTUS, a leading provider in AI infrastructure and liquid-cooling solutions, announced that its AI Compute Pod has received both the 2026 iF Design Award and Red Dot Award. This dual recognition not only stems from its outstanding performance in green, low-energy operation—achieving up to 130 kW cooling capacity per rack and a PUE as low as 1.1 through optimized thermal and power design—but also from its innovative approach to intelligent control and efficient O&M. The solution enables second-level synchronization between cooling and IT workloads, and leverages a dual-group control strategy to improve cooling energy efficiency by over 10%. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye